Holdings
T. Rowe Price Health Sciences Fund, Inc.
As of Jun 30, 2026, T. Rowe Price Health Sciences Fund, Inc. reported 161 positions worth US$11.2B. Largest: Eli Lilly And Company, Johnson & Johnson and Unitedhealth Group Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 1.42M | US$1.71B | +222K | Jun 30, 2026 |
| Johnson & Johnson | 3.12M | US$792M | +2.03M | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 1.72M | US$716M | +479K | Jun 30, 2026 |
| Abbvie Inc. | 2.42M | US$609M | +998K | Jun 30, 2026 |
| Merck & Company, Inc. | 3.73M | US$479M | +609K | Jun 30, 2026 |
| Gilead Sciences, Inc. | 2.67M | US$337M | +633K | Jun 30, 2026 |
| Thermo Fisher Scientific Inc | 601K | US$301M | −300K | Jun 30, 2026 |
| Vertex Pharmaceuticals Incorporated | 548K | US$272M | −43,160 | Jun 30, 2026 |
| Bristol-myers Squibb Company | 4.37M | US$252M | new | Jun 30, 2026 |
| Abbott Laboratories | 2.48M | US$225M | new | Jun 30, 2026 |